Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis

Blood. 2015 Apr 9;125(15):2448-9. doi: 10.1182/blood-2015-01-625491.

¹ French Reference Center for Langerhans Cell Histiocytosis, Trousseau Hospital, Paris, France EA4340, Versailles University, Boulogne-Billancourt, France.
² Biochemistry and Molecular Biology Department, Paul Brousse Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Sud, Villejuif, France.
³ Biodiagnostics Laboratory OncoGenAuvergne, Pathology Unit, Centre Jean Perrin, Clermont-Ferrand, France ERTICa Research Group, EA4677, University of Auvergne, Clermont-Ferrand, France.
⁴ Pathology Department, Ambroise Paré Hospital, Assistance Publique Hôpitaux de Paris, Boulogne-Billancourt, France.
⁵ Pediatric, Adolescent and Young Adult Oncology Department, Institut Curie Medical Center, Paris, France.
⁶ Pathology Department, Robert Debré Hospital, Assistance Publique Hôpitaux de Paris, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
⁷ Biochemistry and Molecular Biology Department, Paul Brousse Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Sud, Villejuif, France.
⁸ Department of Internal Medicine, French Reference Center for Rare, Autoimmune and Systemic Diseases, Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
⁹ EA4340, Versailles University, Boulogne-Billancourt, France Pathology Department, Ambroise Paré Hospital, Assistance Publique Hôpitaux de Paris, Boulogne-Billancourt, France.

No abstract available

Publication types